Inhiprot LLC
Auburn University, AL Doing business as Drug Discovery Research
- UEI
- GSX2BKBLGDM7
- CAGE
- 7LJQ8
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 362 W Thach Concourse, Auburn University, AL 36849, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel inhibitors of PSMB7 and PSMB10 for the treatment of multiple myeloma | National Cancer Institute (NIH) | $296,354 |
Quick answers
Is Inhiprot LLC registered in SAM.gov?
Yes. Inhiprot LLC's SAM.gov registration is active through April 4, 2027.
What is Inhiprot LLC's most recent federal award?
Inhiprot LLC's most recent federal grant award is Novel inhibitors of PSMB7 and PSMB10 for the treatment of multiple myeloma (R41CA221494), from National Cancer Institute (NIH), on September 25, 2017.
On GovTribe
See Inhiprot LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors